|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
multiple interactions |
ISO |
lauric acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] |
CTD |
PMID:19428350 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in increased cleavage of CASP3 protein] |
CTD |
PMID:34506767 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cldn1 |
claudin 1 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
increases hydroxylation decreases hydroxylation |
ISO |
CYP2C9 protein results in increased hydroxylation of lauric acid CYP2C9 gene polymorphism results in decreased hydroxylation of lauric acid |
CTD |
PMID:9241660 PMID:11455026 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases metabolic processing |
ISO |
CYP2E1 protein results in increased metabolism of lauric acid |
CTD |
PMID:12464242 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
affects metabolic processing |
EXP |
CYP4A1 protein affects the metabolism of lauric acid |
CTD |
PMID:15879494 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
affects metabolic processing |
EXP |
CYP4A2 protein affects the metabolism of lauric acid |
CTD |
PMID:15879494 |
|
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
affects metabolic processing |
EXP |
CYP4A3 protein affects the metabolism of lauric acid |
CTD |
PMID:15879494 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [CYP4B1 protein results in increased metabolism of 3,3'-Dichlorobenzidine] |
CTD |
PMID:9310344 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Krt20 |
keratin 20 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of KRT20 protein] |
CTD |
PMID:34506767 |
|
NCBI chr10:84,384,802...84,394,107
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LGR5 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lyz2 |
lysozyme 2 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LYZ protein] |
CTD |
PMID:34506767 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:34506767 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of MUC2 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 1:196,796,257...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
multiple interactions |
ISO |
Curcumin inhibits the reaction [lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]]; lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein] |
CTD |
PMID:18413660 |
|
NCBI chr19:18,379,720...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] |
CTD |
PMID:34506767 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression multiple interactions |
ISO |
lauric acid results in increased expression of PCNA protein lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of PCNA protein] |
CTD |
PMID:34506767 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
affects binding |
ISO |
lauric acid binds to PPARA protein |
CTD |
PMID:10403814 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
lauric acid results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases activity |
ISO |
Curcumin inhibits the reaction [lauric acid results in increased activity of RELA protein]; parthenolide inhibits the reaction [lauric acid results in increased activity of RELA protein] |
CTD |
PMID:18413660 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6 |
ribosomal protein S6 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of RPS6 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions increases expression |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein] lauric acid results in increased expression of TJP1 protein |
CTD |
PMID:34506767 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of lauric acid |
CTD |
PMID:16051554 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vil1 |
villin 1 |
multiple interactions |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of VIL1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 9:75,991,141...76,018,860
Ensembl chr 9:75,991,141...76,018,858
|
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
1-monomyristin inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
increases oxidation affects binding |
ISO |
ADH5 protein results in increased oxidation of 12-hydroxydodecanoic acid 12-hydroxydodecanoic acid binds to ADH5 protein |
CTD |
PMID:12196016 PMID:12604204 PMID:19428350 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Cyp4v3 |
cytochrome P450, family 4, subfamily v, polypeptide 3 |
multiple interactions increases chemical synthesis |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid] |
CTD |
PMID:28729181 |
|
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
|
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
ISO |
lauroyl-coenzyme A binds to and results in decreased activity of GSTA1 protein |
CTD |
PMID:10542059 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
multiple interactions |
ISO |
[lauroyl-coenzyme A co-treated with NADP] binds to HSDL2 protein |
CTD |
PMID:25526675 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
multiple interactions |
ISO |
[lauroyl-coenzyme A co-treated with NADP] binds to PECR protein |
CTD |
PMID:25526675 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
lauric acid methyl ester binds to and results in increased activity of ESR1 protein |
CTD |
PMID:27633901 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
lauric acid methyl ester binds to and results in decreased activity of ESR2 protein; lauric acid methyl ester binds to and results in increased activity of ESR2 protein |
CTD |
PMID:27633901 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
lauric acid methyl ester binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
lauric acid methyl ester binds to and results in decreased activity of PPARG protein |
CTD |
PMID:27633901 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
lauric acid methyl ester binds to and results in decreased activity of THRB protein |
CTD |
PMID:27633901 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of ABCA1 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ABHD14B protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
increases expression multiple interactions |
EXP |
perfluorododecanoic acid results in increased expression of ACOT1 mRNA; perfluorododecanoic acid results in increased expression of ACOT1 protein perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of ACOT1 mRNA]; perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of ACOT1 mRNA]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ACOT1 mRNA] |
CTD |
PMID:26168851 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions increases expression |
EXP ISO |
perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of ACOT2 mRNA]; perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of ACOT2 mRNA]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ACOT2 mRNA] perfluorododecanoic acid results in increased expression of ACOT2 mRNA; perfluorododecanoic acid results in increased expression of ACOT2 protein |
CTD |
PMID:26168851 PMID:35337807 |
|
NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acp1 |
acid phosphatase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of ACP1 protein |
CTD |
PMID:19854247 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ACTG1 protein |
CTD |
PMID:26168851 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
|
|
G |
Acy1 |
aminoacylase 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ACY1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adk |
adenosine kinase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ADK protein |
CTD |
PMID:26168851 |
|
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
|
|
G |
Ahcy |
adenosylhomocysteinase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of AHCY protein |
CTD |
PMID:26168851 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Akap4 |
A-kinase anchoring protein 4 |
increases expression decreases expression |
EXP |
perfluorododecanoic acid results in increased expression of AKAP4 mRNA perfluorododecanoic acid results in decreased expression of AKAP4 protein |
CTD |
PMID:19854247 |
|
NCBI chr X:15,435,391...15,445,684
Ensembl chr X:15,435,410...15,445,684
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
decreases phosphorylation |
EXP |
perfluorododecanoic acid results in decreased phosphorylation of AKT2 protein |
CTD |
PMID:30489073 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alb |
albumin |
increases expression decreases expression |
EXP |
perfluorododecanoic acid results in increased expression of ALB protein perfluorododecanoic acid results in decreased expression of ALB protein |
CTD |
PMID:19854247 PMID:26168851 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression multiple interactions |
EXP |
perfluorododecanoic acid results in decreased expression of ALDH2 protein PPARA mRNA promotes the reaction [perfluorododecanoic acid results in decreased expression of ALDH2 protein] |
CTD |
PMID:26168851 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ALDH9A1 protein |
CTD |
PMID:26168851 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Apoa2 |
apolipoprotein A2 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of APOA2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of APOA4 mRNA |
CTD |
PMID:22071372 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Ar |
androgen receptor |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of AR mRNA |
CTD |
PMID:19397962 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of ARHGDIB protein |
CTD |
PMID:19854247 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of ATF3 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ATP5H mRNA |
CTD |
PMID:19854247 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of BAAT mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of BDH2 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of CCND1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd36 |
CD36 molecule |
increases expression increases uptake |
EXP ISO |
perfluorododecanoic acid results in increased expression of CD36 mRNA CD36 protein results in increased uptake of perfluorododecanoic acid |
CTD |
PMID:23353032 PMID:35380827 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdh5 |
cadherin 5 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of CDH5 protein |
CTD |
PMID:33677611 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cops4 |
COP9 signalosome subunit 4 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of COPS4 protein |
CTD |
PMID:26168851 |
|
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887
|
|
G |
Cops8 |
COP9 signalosome subunit 8 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of COPS8 protein |
CTD |
PMID:19854247 |
|
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
decreases expression increases expression |
EXP |
perfluorododecanoic acid results in decreased expression of COX5A protein perfluorododecanoic acid results in increased expression of COX5A mRNA |
CTD |
PMID:19854247 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of COX5B mRNA |
CTD |
PMID:19854247 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
decreases expression multiple interactions |
EXP |
perfluorododecanoic acid results in decreased expression of CPS1 mRNA; perfluorododecanoic acid results in decreased expression of CPS1 protein PPARA mRNA inhibits the reaction [perfluorododecanoic acid results in decreased expression of CPS1 mRNA] |
CTD |
PMID:26168851 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of CPT1A mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of CRYM protein |
CTD |
PMID:26168851 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csk |
C-terminal Src kinase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of CSK mRNA; perfluorododecanoic acid results in decreased expression of CSK protein |
CTD |
PMID:19854247 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Ctsa |
cathepsin A |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of CTSA protein |
CTD |
PMID:26168851 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Cuta |
cutA divalent cation tolerance homolog |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of CUTA protein |
CTD |
PMID:19854247 |
|
NCBI chr20:5,022,956...5,024,580
Ensembl chr20:5,022,956...5,024,552
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of CYP11A1 mRNA; perfluorododecanoic acid results in decreased expression of CYP11A1 protein |
CTD |
PMID:17400581 PMID:19397962 PMID:19429406 PMID:30489073 PMID:33774092 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of CYP17A1 mRNA; perfluorododecanoic acid results in decreased expression of CYP17A1 protein |
CTD |
PMID:17400581 PMID:30489073 PMID:33774092 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of CYP2B10 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions increases expression |
EXP |
perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of CYP4A1 mRNA]; perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of CYP4A1 mRNA] perfluorododecanoic acid results in increased expression of CYP4A1 mRNA |
CTD |
PMID:26168851 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of DDAH1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of DDIT3 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of DDT protein |
CTD |
PMID:19854247 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Dhh |
desert hedgehog signaling molecule |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of DHH mRNA; perfluorododecanoic acid results in decreased expression of DHH protein |
CTD |
PMID:33774092 |
|
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of DLAT protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
ISO |
[perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid co-treated with perfluoroundecanoic acid co-treated with perfluorododecanoic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid] results in increased expression of DRD2 mRNA |
CTD |
PMID:34371090 |
|
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression multiple interactions |
EXP |
perfluorododecanoic acid results in increased expression of ECH1 mRNA; perfluorododecanoic acid results in increased expression of ECH1 protein PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ECH1 mRNA] |
CTD |
PMID:26168851 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of EFHD2 protein |
CTD |
PMID:19854247 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of EHHADH mRNA |
CTD |
PMID:35337807 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ESR1 mRNA |
CTD |
PMID:19429406 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ESR2 mRNA |
CTD |
PMID:19429406 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of ETHE1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of FABP1 mRNA |
CTD |
PMID:23567314 PMID:35337807 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fasn |
fatty acid synthase |
decreases expression affects expression |
EXP ISO |
perfluorododecanoic acid results in decreased expression of FASN mRNA perfluorododecanoic acid affects the expression of FASN mRNA |
CTD |
PMID:23353032 PMID:35337807 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of FDFT1 mRNA |
CTD |
PMID:22071372 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of FHIT protein |
CTD |
PMID:19854247 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression decreases secretion |
EXP |
perfluorododecanoic acid results in decreased expression of FSHB mRNA; perfluorododecanoic acid results in decreased expression of FSHB protein perfluorododecanoic acid results in decreased secretion of FSHB protein |
CTD |
PMID:19397962 PMID:30489073 PMID:33774092 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of FSHR mRNA; perfluorododecanoic acid results in decreased expression of FSHR protein |
CTD |
PMID:33774092 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Fth1 |
ferritin heavy chain 1 |
decreases expression increases expression |
EXP |
perfluorododecanoic acid results in decreased expression of FTH1 protein perfluorododecanoic acid results in increased expression of FTH1 mRNA |
CTD |
PMID:19854247 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of GADD45B mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gc |
GC, vitamin D binding protein |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of GC protein |
CTD |
PMID:26168851 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gk |
glycerol kinase |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of GK mRNA |
CTD |
PMID:23567314 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glod4 |
glyoxalase domain containing 4 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of GLOD4 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898
|
|
G |
Gmfb |
glia maturation factor, beta |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of GMFB protein |
CTD |
PMID:26168851 |
|
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
|
|
G |
Gmfg |
glia maturation factor, gamma |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of GMFG protein |
CTD |
PMID:19854247 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of GNRHR mRNA |
CTD |
PMID:19397962 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of GPAM mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of GPD1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
decreases expression affects response to substance |
EXP |
perfluorododecanoic acid results in decreased expression of GSK3A protein; perfluorododecanoic acid results in decreased expression of GSK3A protein modified form GSK3A protein affects the susceptibility to perfluorododecanoic acid |
CTD |
PMID:23353032 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
affects response to substance decreases expression |
EXP |
GSK3B protein affects the susceptibility to perfluorododecanoic acid perfluorododecanoic acid results in decreased expression of GSK3B protein; perfluorododecanoic acid results in decreased expression of GSK3B protein modified form |
CTD |
PMID:23353032 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of GSTA1 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HAAO protein |
CTD |
PMID:26168851 |
|
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
affects expression multiple interactions increases expression |
ISO EXP |
perfluorododecanoic acid affects the expression of HADHA mRNA PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of HADHA mRNA] perfluorododecanoic acid results in increased expression of HADHA mRNA; perfluorododecanoic acid results in increased expression of HADHA protein |
CTD |
PMID:22071372 PMID:23567314 PMID:26168851 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HADHB mRNA |
CTD |
PMID:22071372 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hhex |
hematopoietically expressed homeobox |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HHEX mRNA |
CTD |
PMID:22071372 |
|
NCBI chr 1:235,190,455...235,196,042
Ensembl chr 1:235,190,455...235,196,042
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of HMGCS1 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of HMOX1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpx |
hemopexin |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HPX protein |
CTD |
PMID:26168851 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of HSD11B1 mRNA; perfluorododecanoic acid results in decreased expression of HSD11B1 protein |
CTD |
PMID:30489073 PMID:33774092 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:19429406 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of HSD17B2 mRNA |
CTD |
PMID:33774092 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases expression affects expression |
EXP |
perfluorododecanoic acid results in decreased expression of HSD17B3 mRNA perfluorododecanoic acid affects the expression of HSD17B3 protein |
CTD |
PMID:17400581 PMID:33774092 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression decreases activity affects expression |
EXP ISO |
perfluorododecanoic acid results in decreased expression of HSD3B1 mRNA; perfluorododecanoic acid results in decreased expression of HSD3B1 protein perfluorododecanoic acid results in decreased activity of HSD3B1 protein perfluorododecanoic acid affects the expression of HSD3B1 mRNA; perfluorododecanoic acid affects the expression of HSD3B1 protein |
CTD |
PMID:17400581 PMID:33774092 PMID:36122607 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of HSPA5 protein |
CTD |
PMID:26168851 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HSPA8 protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HSPA9 protein |
CTD |
PMID:26168851 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of HSPD1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IDH3A protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of IDO1 protein |
CTD |
PMID:19854247 |
|
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ift20 |
intraflagellar transport 20 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IFT20 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IGF1 mRNA |
CTD |
PMID:19397962 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IGF1R mRNA |
CTD |
PMID:19397962 |
|
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IL1A mRNA |
CTD |
PMID:19397962 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Impa1 |
inositol monophosphatase 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IMPA1 protein |
CTD |
PMID:19854247 |
|
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IRS1 protein modified form |
CTD |
PMID:23353032 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Itga1 |
integrin subunit alpha 1 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of ITGA1 protein |
CTD |
PMID:33677611 |
|
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
|
|
G |
Itpa |
inosine triphosphatase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of ITPA protein |
CTD |
PMID:26168851 |
|
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
|
|
G |
Ivd |
isovaleryl-CoA dehydrogenase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of IVD protein |
CTD |
PMID:26168851 |
|
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
|
|
G |
Krt10 |
keratin 10 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of KRT10 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Krt14 |
keratin 14 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of KRT14 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:85,137,932...85,141,990
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt16 |
keratin 16 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of KRT16 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:85,168,357...85,171,744
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt8 |
keratin 8 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of KRT8 protein |
CTD |
PMID:26168851 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression decreases secretion |
EXP |
perfluorododecanoic acid results in decreased expression of LHB mRNA; perfluorododecanoic acid results in decreased expression of LHB protein perfluorododecanoic acid results in decreased secretion of LHB protein |
CTD |
PMID:17400581 PMID:19397962 PMID:30489073 PMID:33774092 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression affects expression |
EXP |
perfluorododecanoic acid results in decreased expression of LHCGR mRNA; perfluorododecanoic acid results in decreased expression of LHCGR protein perfluorododecanoic acid affects the expression of LHCGR mRNA; perfluorododecanoic acid affects the expression of LHCGR protein |
CTD |
PMID:19429406 PMID:30489073 PMID:33774092 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of LHPP protein |
CTD |
PMID:26168851 |
|
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
|
|
G |
Mbl2 |
mannose binding lectin 2 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of MBL2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of MDH1 protein |
CTD |
PMID:26168851 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of MTTP mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mug2 |
murinoglobulin 2 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PZP protein |
CTD |
PMID:26168851 |
|
NCBI chr 4:155,164,061...155,236,765
Ensembl chr 4:155,164,011...155,236,475
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of NDUFV2 protein |
CTD |
PMID:26168851 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of NOS2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
perfluorododecanoic acid results in increased activity of NR1I2 protein |
CTD |
PMID:28115241 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of NR1I3 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Ntan1 |
N-terminal asparagine amidase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of NTAN1 protein |
CTD |
PMID:19854247 |
|
NCBI chr10:2,111,085...2,126,123
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of P4HB protein |
CTD |
PMID:26168851 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Park7 |
Parkinsonism associated deglycase |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PARK7 protein |
CTD |
PMID:19854247 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Pax8 |
paired box 8 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of PAX8 mRNA |
CTD |
PMID:22071372 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PBLD1 protein |
CTD |
PMID:26168851 |
|
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of PCK2 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of PDHB protein |
CTD |
PMID:26168851 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of PDIA6 protein |
CTD |
PMID:26168851 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of PDK4 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
decreases activity decreases expression |
EXP |
perfluorododecanoic acid results in decreased activity of PDPK1 protein perfluorododecanoic acid results in decreased expression of PDPK1 protein; perfluorododecanoic acid results in decreased expression of PDPK1 protein modified form |
CTD |
PMID:23353032 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
decreases expression increases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PEBP1 protein perfluorododecanoic acid results in increased expression of PEBP1 mRNA |
CTD |
PMID:19854247 |
|
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
|
|
G |
Phb1 |
prohibitin 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of PHB1 protein |
CTD |
PMID:26168851 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Pitpna |
phosphatidylinositol transfer protein, alpha |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PITPNA protein |
CTD |
PMID:19854247 |
|
NCBI chr10:60,430,712...60,473,564
Ensembl chr10:60,430,748...60,471,342
|
|
G |
Plin2 |
perilipin 2 |
increases expression affects expression |
ISO |
perfluorododecanoic acid results in increased expression of PLIN2 mRNA perfluorododecanoic acid affects the expression of PLIN2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 5:101,156,643...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of POR mRNA |
CTD |
PMID:23567314 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases activity increases expression increases response to substance multiple interactions |
ISO EXP |
perfluorododecanoic acid results in increased activity of PPARA protein perfluorododecanoic acid results in increased expression of PPARA mRNA PPARA mRNA results in increased susceptibility to perfluorododecanoic acid perfluorododecanoic acid results in increased expression of PPARA mRNA; perfluorododecanoic acid results in increased expression of PPARA protein perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of PPARA mRNA]; perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of PPARA mRNA]; PPARA mRNA inhibits the reaction [perfluorododecanoic acid results in decreased expression of CPS1 mRNA]; PPARA mRNA inhibits the reaction [perfluorododecanoic acid results in increased abundance of Reactive Oxygen Species]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in decreased expression of ALDH2 protein]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ACOT1 mRNA]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ACOT2 mRNA]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of ECH1 mRNA]; PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of HADHA mRNA] |
CTD |
PMID:22107727 PMID:26168851 PMID:28857218 PMID:35337807 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of PPARD mRNA |
CTD |
PMID:23567314 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity increases expression |
ISO |
perfluorododecanoic acid results in increased activity of PPARG protein perfluorododecanoic acid results in increased expression of PPARG mRNA |
CTD |
PMID:23391484 PMID:24998974 PMID:35337807 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PPARGC1A protein |
CTD |
PMID:30489073 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prdx2 |
peroxiredoxin 2 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PRDX2 protein |
CTD |
PMID:26168851 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx4 |
peroxiredoxin 4 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PRDX4 protein |
CTD |
PMID:26168851 |
|
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
|
|
G |
Psmf1 |
proteasome inhibitor subunit 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of PSMF1 protein |
CTD |
PMID:19854247 |
|
NCBI chr 3:140,235,371...140,260,546
Ensembl chr 3:140,235,373...140,260,546
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
multiple interactions |
ISO |
perfluorododecanoic acid binds to and results in decreased activity of PTPN11 protein |
CTD |
PMID:27572461 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ranbp1 |
RAN binding protein 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of RANBP1 protein |
CTD |
PMID:19854247 |
|
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
|
|
G |
Rbp4 |
retinol binding protein 4 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of RBP4 protein |
CTD |
PMID:26168851 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rgn |
regucalcin |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of RGN protein |
CTD |
PMID:26168851 |
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression affects expression |
EXP |
perfluorododecanoic acid results in decreased expression of SCARB1 mRNA; perfluorododecanoic acid results in decreased expression of SCARB1 protein perfluorododecanoic acid affects the expression of SCARB1 mRNA; perfluorododecanoic acid affects the expression of SCARB1 protein |
CTD |
PMID:17400581 PMID:30489073 PMID:33774092 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression increases expression |
ISO EXP |
perfluorododecanoic acid results in decreased expression of SCD mRNA perfluorododecanoic acid results in increased expression of SCD1 mRNA |
CTD |
PMID:23353032 PMID:23567314 PMID:35337807 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Serpind1 |
serpin family D member 1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of SERPIND1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519
|
|
G |
Serpinf2 |
serpin family F member 2 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of SERPINF2 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr10:60,272,400...60,280,506
Ensembl chr10:60,272,400...60,281,243
|
|
G |
Sirt1 |
sirtuin 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of SIRT1 protein |
CTD |
PMID:30489073 |
|
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of SLC25A20 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
increases expression |
ISO |
perfluorododecanoic acid results in increased expression of SLC27A1 mRNA |
CTD |
PMID:23567314 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression affects expression |
EXP ISO |
perfluorododecanoic acid results in decreased expression of SOD1 mRNA perfluorododecanoic acid affects the expression of SOD1 mRNA |
CTD |
PMID:19854247 PMID:35337807 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of SOX9 mRNA; perfluorododecanoic acid results in decreased expression of SOX9 protein |
CTD |
PMID:33774092 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
affects expression |
EXP |
perfluorododecanoic acid affects the expression of SRD5A1 mRNA |
CTD |
PMID:33774092 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
EXP ISO |
perfluorododecanoic acid results in increased expression of SREBF1 mRNA |
CTD |
PMID:23353032 PMID:35337807 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions affects expression decreases expression |
ISO EXP |
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [perfluorododecanoic acid inhibits the reaction [Cyclic AMP results in increased expression of STAR mRNA]]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [perfluorododecanoic acid inhibits the reaction [Cyclic AMP results in increased expression of STAR protein]]; perfluorododecanoic acid inhibits the reaction [Cyclic AMP results in increased expression of STAR mRNA]; perfluorododecanoic acid inhibits the reaction [Cyclic AMP results in increased expression of STAR protein] perfluorododecanoic acid affects the expression of STAR mRNA; perfluorododecanoic acid affects the expression of STAR protein perfluorododecanoic acid results in decreased expression of STAR mRNA; perfluorododecanoic acid results in decreased expression of STAR protein |
CTD |
PMID:17400581 PMID:19397962 PMID:19429406 PMID:20100736 PMID:30489073 PMID:33774092 More...
|
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of STMN1 protein |
CTD |
PMID:19854247 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Suclg2 |
succinate-CoA ligase GDP-forming subunit beta |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of SUCLG2 protein |
CTD |
PMID:26168851 |
|
NCBI chr 4:128,067,031...128,337,146
Ensembl chr 4:128,067,033...128,337,170
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of SULT1C3 protein |
CTD |
PMID:26168851 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of SULT2A1 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 1:75,451,178...75,508,142
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Suox |
sulfite oxidase |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of SUOX protein |
CTD |
PMID:26168851 |
|
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
[perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid co-treated with perfluoroundecanoic acid co-treated with perfluorododecanoic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid] results in decreased expression of TH mRNA |
CTD |
PMID:34371090 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thra |
thyroid hormone receptor alpha |
affects binding |
ISO |
perfluorododecanoic acid binds to THRA protein |
CTD |
PMID:24819616 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Tpm1 |
tropomyosin 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of TPM1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of TRAP1 protein |
CTD |
PMID:26168851 |
|
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
|
|
G |
Ttr |
transthyretin |
multiple interactions |
ISO |
perfluorododecanoic acid affects the reaction [Thyroxine binds to TTR protein] |
CTD |
PMID:27528273 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Txnip |
thioredoxin interacting protein |
affects expression |
ISO |
perfluorododecanoic acid affects the expression of TXNIP mRNA |
CTD |
PMID:23567314 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
decreases expression |
EXP |
perfluorododecanoic acid results in decreased expression of UBE2N protein |
CTD |
PMID:19854247 |
|
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases expression |
ISO |
perfluorododecanoic acid results in decreased expression of UGT1A1 mRNA |
CTD |
PMID:35337807 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein 1 |
increases expression |
EXP |
perfluorododecanoic acid results in increased expression of UQCRC1 protein |
CTD |
PMID:26168851 |
|
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
decreases expression increases expression |
EXP |
perfluorododecanoic acid results in decreased expression of UQCRH protein perfluorododecanoic acid results in increased expression of UQCRH mRNA |
CTD |
PMID:19854247 |
|
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
decreases expression increases expression |
EXP |
perfluorododecanoic acid results in decreased expression of YWHAE protein perfluorododecanoic acid results in increased expression of YWHAE mRNA |
CTD |
PMID:19854247 |
|
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
|
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
1-monomyristin inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|